DCK confers sensitivity of DCTD-positive cancer cells to oxidized methylcytidines-Reference-Cited by-全球学者库

DCK confers sensitivity of DCTD-positive cancer cells to oxidized methylcytidines

Published:2022-07-15 Issue: Volume: Page:
ISSN:1674-800X
Container-title:Protein & Cell
language:en
Short-container-title:

Author:

Zhao Ya-Hui¹^ORCID,Jiang Wei²,Gao Hai¹³,Pang Guo-Zheng¹,Wu Yu-Shuang¹,Wang Yuan-Xian¹,Sheng Meng-Yao¹,Xie Jia-Ying¹,Wu Wan-Ling⁴,Ji Zhi-Jian²,Du Ya-Rui²,Zhang Lei⁵,Wang Xiao-Qin⁴,Walsh Colum P⁶⁷,Jiang Hai²^ORCID,Xu Guo-Liang¹²^ORCID,Zhou Dan¹³^ORCID

Affiliation:

1. Shanghai Key Laboratory of Medical Epigenetics, Laboratory of Cancer Epigenetics, Institutes of Biomedical Sciences, Medical College of Fudan University, Chinese Academy of Medical Sciences (RU069) , Shanghai 200032 , China

2. State Key Laboratory of Molecular Biology, Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences , Shanghai 200031 , China

3. Center for Medical Research and Innovation, Shanghai Pudong Hospital, Fudan University , Shanghai 201399 , China

4. Department of Hematology, Huashan Hospital of Fudan University , Shanghai 200040 , China

5. Department of Chemistry and Institutes of Biomedical Science, Shanghai Medical College, Fudan University , Shanghai 200032 , China

6. Genomic Medicine Research Group, Biomedical Sciences, Ulster University , Coleraine BT52 1SA , United Kingdom

7. Centre for Research and Development, Region Gävleborg/Uppsala University , Gävle SE-801 87 , Sweden

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Drug Discovery,Biochemistry,Biotechnology

Link

https://academic.oup.com/proteincell/advance-article-pdf/doi/10.1093/procel/pwac028/48362304/pwac028.pdf

Reference15 articles.

1. Acute myeloid leukemia;Appelbaum;N Engl J Med,1999

2. A subset of platinum-containing chemotherapeutic agents kills cells by inducing ribosome biogenesis stress;Bruno;Nat Med,2017

3. High cytidine deaminase expression in the liver provides sanctuary for cancer cells from decitabine treatment effects;Ebrahem;Oncotarget,2012

4. Targeting the nucleotide salvage factor DNPH1 sensitizes BRCA-deficient cells to PARP inhibitors;Fugger;Science,2021

5. Degradation of 1-beta-D- arabinofuranosylcytosine 5’-triphosphate in human leukemic myeloblasts and lymphoblasts;Jamieson;Cancer Res,1987